Drugs / Yiqi Wenyang Jiedu prescription
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT05229809 | Mar 2022 → Jul 2023 | gastric carcinoma | Jie Li | Unknown | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Yiqi Wenyang Jiedu prescription | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05229809 ↗ |
| Known as | YWJP | “The Yiqi Wenyang Jiedu prescription (YWJP), a form of complementary and alternative medicine in China, is an empirical remedy to prevent postoperative recurrence and metastasis of GC.” PMID 39035732 ↗ Jul 2024 |
| Modality | Traditional medicine (herbal / TCM) | “a form of complementary and alternative medicine in China” PMID 39035732 ↗ Jul 2024 |
| Route | Oral | “The medicine needs to be melted in hot water before being taken.” NCT05229809 ↗ |